万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://febs.onlinelibrary.wiley.com/journal/18733468
3、投稿网址：https://mc.manuscriptcentral.com/febsl
4、官网邮箱：
febs.letters@bzh.uni-heidelberg.de（编辑部）
5、期刊刊期：半月刊，一年出版二十四期。
2021年4月16日星期五
投稿须知【官网信息】
Author Guidelines
Author guidelines for those looking to publish with FEBS Letters can be found in PDF format HERE.
INTRODUCTION
Aims and Scope
Fast-Track Publication
BEFORE YOU BEGIN
Ethical standards
Work involving human or animal subjects or tissues
Conflict of interest
Submission declaration and verification
Authorship
Author Contributions
Role of the funding source
Open access options
Funding body agreements and policies
MANUSCRIPT PREPARATION
Article Formats
Research Article
Research Letters
Hypotheses
Communications
Reviews
Perspectives
In a Nutshell
Scientists’ Forum
Commentaries
New Submissions
Revised Submissions
Article Structure (Research Letters)
Title
Abstract
Manuscript Text
References
Figure Preparation
Tables
Supporting Information
Electronic Artwork
Database linking and Accession numbers
Data Accessibility
Standards of Reporting
Reviewers
Article Preparation Support
Initial submission
AFTER ACCEPTANCE
Copyright
Accepted Articles
Proofs
Article Promotion Support
Early View
Page charges and Offprints
Changes to authorship
AUTHOR ENQUIRIES
Information about FEBS Letters
Introduction
FEBS Letters is a world-renowned journal for rapid publication of reports describing novel and specific biological or biochemical functions. Bringing together important developments in molecular biosciences, FEBS Letters provides an international forum for Research Articles, Research Letters, Reviews, Hypotheses, Commentaries and Communications. FEBS Letters articles typically report or discuss novel findings, which appeal to a broad readership, and provide molecular mechanistic insight. FEBS Letters is published by Wiley on behalf of the Federation of European Biochemical Societies (FEBS).
Aims and scope
Papers should be complete and essentially final reports. The subject area of FEBS Letters is broad. Articles can be classified under the following categories: Bioenergetics; Biophysics, Cell fate determination (cell cycle, cell differentiation, cell death); Chemical Biology; Computation Biology (genomics, proteomics, bioinformatics); Cytoskeleton; Development; Enzymology; Evolution; Genome organization and stability; Glycobiology; Immunology; Membrane Biology (membrane trafficking, vesicles, organelles); Metabolism; Microbiology; Molecular basis of disease; Neuroscience; Plant Biology; Protein Chemistry; Protein Homeostasis; Redox Biology; Regulation of gene expression; RNA Biology; Signal Transduction; Structural Biology; Synthetic Biology; Systems Biology; and Virology.
As a general policy, FEBS Letters does not consider preliminary or fragmentary observations, cloning and sequencing of cDNA or genes that have previously been reported for other species, conventionally achieved expression or crystallization of proteins, description of the effect of a drug or reagent without elucidation of a detailed molecular mechanism, correlative studies or negative observations. Moreover, methodological papers are considered for publication only when they are truly novel and significant, and interesting to a broad readership.
Fast-track publication
FEBS Letters offers expedited handling of manuscripts that have been rejected with reviews from highly ranked journals. The submission should enclose reviews, comments from the editor, and the final decision letter. You will receive a decision from the handling Editor or the Editorial Office within a few days of submitting your manuscript.
Editorial policies
Ethical standards
FEBS Letters adheres to international standards of ethics in publishing. Data manipulation, inappropriate image processing, plagiarism, and any sort of scientific fraud are not tolerated and will be investigated. The journal will take action where misconduct is suspected, along the lines of the general principles outlined in Guidelines on Good Publication Practice, produced by the Committee on Publication Ethics (COPE). The Guidelines are available from the COPE website (www.publicationethics.org).
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright holder. To verify originality, articles are routinely checked by the originality detection software iThenticate.
Work involving human or animal subjects or tissues
The work described in your article must have been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/, EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm, Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. This must be stated at an appropriate point in the article.
If human subjects are used, manuscripts must be accompanied by a statement in the Methods section, indicating that:
The experiments were undertaken with the understanding and written consent of each subject.
The study methodologies conformed to the standards set by the Declaration of Helsinki.
The study methodologies were approved by the local ethics committee.
Authors should ensure that all risks are minimised and the subjects are not injured and do not feel they have been abused as a result of participating in the study. Fully informed consent should always be sought.
In cases of experiments involving minors, in addition to meeting above mentioned precautions, evidence must be presented that the experiments were performed with the understanding and consent of the legal guardian.
FEBS Letters endorses the updated ARRIVE 2.0 Guidelines for reporting in vivo animal experiments. Whenever appropriate, authors should include in the Materials and Methods section:
A statement indicating that the experiments were performed in accordance with named national legislation, where it exists, or, in its absence, with the named institutional/local body concerned with the ethics of experimentation (e.g. the National Research Council, or NIH in the USA). Experiments should be carried out in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC) or with the Guidelines laid down by the NIH in the USA regarding the care and use of animals for experimental procedures.
A full description of the anaesthetic and surgical procedures used, and of peri-operative care.
Evidence that authors took adequate steps to ensure that animals did not suffer.
The Editor reserves the right to reject a paper if there is doubt as to whether appropriate procedures have been used.
Conflicts of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Authors are required to meet the criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE).
Author contributions
Detailed information about the specific contributions of every author should be provided. Please list all authors with their initials.
Example of Author Contributions statement:
AB and DJ conceived and supervised the study; AB and KL designed experiments; KL, DG and DGN performed experiments; AG provided new tools and reagents; KG developed new software and performed simulation studies; KL and DGN analysed data; KL, AB and DJ wrote the manuscript; KL and AB made manuscript revisions.
Requests to add or remove an author, or to rearrange the author names, must be sent to the Editorial Officeand must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Any requests to add, delete or rearrange author names in already published article will follow the same policies as noted above and result in a corrigendum.
Preprints and data availability
Preprints
FEBS Letters supports rapid and open scientific communication. Authors are free to upload their work to their personal website, their company’s/institution’s repository or archive, or a not-for-profit subject-based preprint server or repository ahead of or concurrently with submission to the Journal. Posting a manuscript to a recognised preprint server does not constitute prior publication.
Standards of reporting
Authors should comply with available field-specific standards for the preparation and recording of data. Please refer to the Minimum Information for Biological and Biomedical Investigations (MIBBI) Portal for prescriptive checklists for reporting biological and biomedical research where applicable: http://mibbi.sourceforge.net/.
Article Formats
Research Articles
Research Articles are full-length articles reporting primary research with at least 6 figures. Although there is no word limit, the Author should keep in mind that longer papers might take longer to review.
Research Letters
Research Letters are short articles (up to 4500 words, excluding figure legends, tables and references) reporting primary research. They should contain a maximum of 5 figures. Importantly, they should be self-explanatory and conclusive.
Hypotheses
Hypotheses should present novel ideas or new interpretations of established observations, but should be based on sound, novel data and avoid excessive speculation. Hypotheses must be of general interest. Prior to submitting a Hypothesis, authors should contact the Editorial Office at febs.letters@bzh.uni-heidelberg.de, providing a title, abstract and key references of the article to be considered, as well as full names and affiliations of all authors.
Communications
Communications are short (up to 4500 words), peer-reviewed articles that expand or comment on previously published papers. Communications should contain new experimental data that provide a novel perspective to previously published results, possibly indicating caveats and discrepancies, or offering alternative interpretations. Prior discussion with the authors of the primary publication would be desirable. The results of such a correspondence may be included to the submission in the cover letter.
Reviews
Reviews should be topical and of interest not only to specialists in the field but also to the general reader. Reviews do not have a word limit. We encourage authors to cite all primary literature in the review, as there is no limit to the references either. Prior to submitting a Review, authors should contact the Editorial Office at febs.letters@bzh.uni-heidelberg.de, providing a title, abstract and key references of the article to be considered, as well as full names and affiliations of all authors.
Perspectives
Perspectives are Review articles that put forward solid hypotheses, opinions, or previously unpublished models. Authors’ opinions should be clearly labelled as such and placed in a general context through the detailed discussion of the literature and of questions remaining open. Occasionally, this Review article format may include novel analysis of systems biology data to support the author perspectives. Similarly to Review articles, Perspectives are subject to peer review, and thus need to be accurate, balanced and scientifically sound.
In a Nutshell
In a Nutshell articles are Reviews that aim to introduce fast-evolving fields or emerging concepts to a broader audience of biochemists and molecular biologists. They are shorter than regular Review articles (2000-3000 words) and are addressed to a wider readership.
The Scientists’ Forum
News articles, interviews, or letters to the editors putting forward the perspective of visible researchers on Science Policy, Publishing, Ethics and other topics of interest.
Commentaries
Commentaries are invited contributions that discuss and contextualise recently published research.
Preparing your manuscript
Your article may qualify for Fast-Track handling. Find out more in the Fast-Track Publication section.
Format of initial submission
Initial submissions to FEBS Letters may be made in any format, including as a single file. All manuscripts must contain the essential elements needed to convey your manuscript, for example Title, Author names and affiliations, Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Figures and Tables with Captions.
Title
The title should be a maximum of 150 characters (including spaces). FEBS Letters reserves the right to edit titles for length and clarity. Your title should be concise but informative and contain keywords. See Wiley's guide for suggestions on how to optimise your title and abstract for search engine discoverability. Avoid acronyms for protein/gene names, unless standard and widely known.
Author names and affiliations
Names should appear below the title, with the first or middle name of each author given in full. Given names should appear first. The full names and affiliations should be provided for all authors (also in the online submission system). The laboratories where the work was carried out should be given below the authors’ names. If the work was carried out at more than one laboratory, the names of the authors should be followed by superscript numbers, which should also precede the names of the appropriate laboratories. The corresponding author should also provide a full postal address, telephone number (including country code), and an e-mail address.
Keywords
Define non-standard or uncommon abbreviations. They should be defined unless included in the table of accepted abbreviations. They should be introduced only if essential owing to frequent repetition or excessive length of the full name.
Abbreviations
Define non-standard or uncommon abbreviations. They should be defined unless included in the table of accepted abbreviations. They should be introduced only if essential owing to frequent repetition or excessive length of the full name.
Abstract
The abstract should be a maximum of 120 words (180 for reviews). The abstract should clearly state the purpose of the research, the principal results, major conclusions, and overall significance of the study.There should be a clear distinction between former findings mentioned and the findings reported in the study. Avoid non-standard or uncommon abbreviations, acronyms and formulae where possible. Abbreviations and acronyms should be spelt out the first time they appear in the abstract and in the main text. Use keywords to optimize search engine discoverability. FEBS Letters reserves the right to edit abstracts for length and clarity.
Manuscript text
There is no word limit if you are submitting a Research Article. If you choose the Research Letter article format, the length of the submitted manuscript should not exceed 4500 words, excluding figure legends, tables, and references. Ideally, the manuscript text should be divided in the following sections:
Introduction
Materials and Methods
Results
Discussion
(or Results and Discussion)
Acknowledgements
References
Figure legends
Acknowledgements
Authors must include all funding grant numbers in the Acknowledgments section of the manuscript.
Funding sources and disclosure of conflicts of interest
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
References
The number and length of references is not limited. FEBS Letters strongly encourages citation of primary literature in favour of reviews where appropriate.
FEBS Letters uses a numbered system for references. There are no strict requirements on reference formatting. References can be in any style or format as long as the style is consistent. Author(s) name(s), journal title / book title, article title, year of publication, volume & issue / book chapter and the pagination must be present. The reference style required by the journal will be applied to the published version by Wiley.
Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. Citation of a reference as 'in press' implies that the item has been accepted for publication. The use of a tool such as EndNote is recommended for reference management and formatting. The EndNote reference style for FEBS Letters can be found here.
Tables
Number tables consecutively in accordance with their appearance in the text. These must be supplied as editable text and not as embedded figures/objects. They should have a bold title and appear in the text following the references. Experimental conditions and general remarks should appear in a legend between the title and the table. They should not reproduce the detail given in Materials and Methods. Footnotes should be used only if information cannot be included in the legend; they should be indicated by superscript lower-case letters. All columns should have a heading; units should appear under the column heading(s).
Figure legends
Figure legends should appear in the text document following the references, each with a title, and be comprehensible without reference to the text. The figure title must be relevant to the entire figure. Supplementary figure legends should be included in the actual supplementary figure files.
If applicable, error bars should be defined as s.d. or s.e.m. and a precise n value given. Where statistical tests have been used to calculate significance (or lack thereof) the p value should be defined and the name of the statistical test provided in the relevant legend.
Figures
Please make sure that figure files are in an acceptable format (TIFF, EPS, PDF or MS Office files) and that the resolution is at least 300dpi and figure size 10x250px. TIFF files may be saved with using LZW compression. Figure manipulation should be reduced to the minimum, in keeping with the following requirements:
No specific feature within an image may be selectively enhanced, obscured, moved, removed, or introduced.
The grouping of images from different parts of the same gel, or from different gels, fields, or exposures, must be explicitly labelled both on the figure (i.e., using dividing lines) and in the text of the figure legend. Controls must be on the same blot/gel.
Adjustments of brightness, contrast, or colour balance are acceptable if they are applied to every pixel in the image and as long as they do not obscure, eliminate, or misrepresent any information present in the original, including the background.
In protein or nucleic acid blots or gels the background should be visible but not oversaturated.
In fluorescence images the manipulation of single channels is not allowed.
All digital images in manuscripts accepted for publication will be scrutinized by our figure checking service for any indication of manipulation that is inconsistent with the above guidelines. Manipulation that violates these guidelines may result in production delays or revocation of acceptance. The editors reserve the right to request original data from authors at any stage in the publication process, including post-publication.
For further information on the preparation of artwork, please see https://authorservices.wiley.com/asset/photos/electronic_artwork_guidelines.pdf.
Supporting information
Supporting data for an article appears in the Supporting information section of an article on the journal website; it is accessible via a hyperlink and can be downloaded separately.
Supporting information is peer-reviewed material directly relevant but not essential to the conclusion of an article, such as control experiments, supporting data tables or movies. The article must be complete and self-explanatory without this additional information. It is not edited. So before submission, consider carefully how any additional data supports the paper.
File sizes must be as small as possible, so that they can be downloaded quickly, so please submit supporting information as PDFs where possible. When not possible, accepted formats are
HTML files (.html),
movie files (.mov/.mpg), and
audio files (.wav/.mp3/.wma).
Electronic artwork
General points
Make sure you use uniform lettering and sizing of your original artwork.
Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, Courier.
Number the illustrations according to their sequence in the text.
Use a logical naming convention for your artwork files.
Indicate per figure if it is a single, 1.5 or 2-column fitting image.
For Word submissions only, you may still provide figures and their captions, and tables within a single file at the revision stage.
Please note that individual figure files larger than 10 MB must be provided in separate source files
A detailed guide on electronic artwork is available on our website:
https://authorservices.wiley.com/author-resources/book-authors/prepare-your-manuscript/artwork.html
Formats
Regardless of the application used, when your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below): EPS: Vector drawings. Embed the font or save the text as 'graphics'. TIFF: Colour or grayscale photographs (halftones): always use a minimum of 300 dpi. TIFF: Bitmapped line drawings: use a minimum of 1000 dpi. TIFF: Combinations bitmapped line/half-tone (colour or grayscale): a minimum of 500 dpi is required. If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.
Please do not:
Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
Supply files that are too low in resolution;
Submit graphics that are disproportionately large for the content.
Nomenclature, abbreviations, units and symbols
FEBS Letters prefers abbreviations and nomenclature to follow internationally agreed recommendations, e.g. those of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (see www.chem.qmw.ac.uk/iubmb/nomenclature). However:
Authors may use commonly used abbreviations and acronyms, but these must be defined in the text at first citation and included in the Abbreviations list.
SI units and quantities should be used (see http://www.bipm.fr/enus/3_SI/si.html) but Å, cal, p.p.m. can be used where appropriate.
It is often convenient, especially in figures and table headings, to give a multiple of the quantity set or measured by multiplying it by a stated factor. The units in which it is expressed should not be multiplied by a number but may be indicated by prefixes such as: M, k, m, µ, n or p.
A negative index style is used for units.
Square brackets are commonly used to indicate concentrations.
Math formulae
Please submit math equations as editable text and not as images. Present simple formulae in line with normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text).
Authors should not use Microsoft Word 2007 equation tool to supply equations. Instead, authors should use the Mathtype plug-in, an equation editor for Word that is freely available to download.
Database linking and accession numbers
FEBS Letters aims at connecting online articles with external databases, which are useful in their respective research communities. In accordance with the journal’s policy to make published data easily accessible and freely available, FEBS Letters requires authors to deposit large datasets such as sequences, structural data or computational models in relevant public databases. If your article contains unique identifiers or accession numbers linking to information on entities (genes, proteins, diseases, etc.) or structures deposited in public databases, then please indicate those entities according to the standards for the respective identifiers. Please use the following format: Database ID: xxx.
Data availability
FEBS Letters expects that data supporting the results in the paper will be archived in an appropriate public repository, where available. Authors of Research Articles, Research Letters, Communications and Hypotheses are required to provide a statement of Data Availability which should briefly describe the availability of the supporting data, whether contained in the manuscript (as Supplementary Information), deposited elsewhere, or any exceptions or limitations to the sharing of data or materials. Large-scale or structured datasets must be deposited in appropriate public databases and a link to the repository and the persistent identifier of the dataset (e.g. DOI or accession number) should be included in the data availability statement. Whenever possible, the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. Authors are not expected to share data that is sensitive in nature or should not be made publicly available due to privacy, security, and/or safety concerns, such as human subject data or the location of endangered species. See https://febs.onlinelibrary.wiley.com/hub/data-policy for standard templates to follow when compiling your data availability statement (Table 1) and for details of suitable repositories for structured datasets (Table 2).
English language editing services
All papers must be in English. Non-English-speaking authors who do not have a good command of English are advised to seek assistance from someone who has. Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
Online submission
New submissions
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts your files to a single PDF file, which is used in the peer-review process.
Please submit the names, addresses and e-mail addresses of potential reviewers. You can also specify whom you would like to exclude from reviewing the manuscript. Note that the Editor retains the sole right to decide whether the suggested and excluded reviewers are used or not.
Revised submissions
When submitting a revision, authors are asked to upload the revised manuscript text, tables and figures, each as independent source files. Ideally, the figures should be uploaded as separate print-quality files in PDF, TIFF or EPS format. A point-by-point response to the Reviewers’ comments must be uploaded online.
For questions on the submission process, please contact the Editorial Office prior to submission at febs.letters@bzh.uni-heidelberg.de. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail. For general information about publishing with Wiley see: http://exchanges.wiley.com/authors/authors_268.html
LaTeX article submission
FEBS Letters can receive submissions in LaTeX. Please use ‘article’ class for LaTeX submissions and include any associated packages/files with the submitted LaTeX source files. Please also include a PDF of the manuscript. Do not add coding to ‘force’ line breaks or the positioning of ‘floats’, as these will need to be removed in the processing of your manuscript.
If you wish to use a citation package such as BibTeX and natbib.sty, then please do so. There is no bespoke ‘.bst’ file for FEBS Letters. Please provide all the necessary bibliographic information in a standard format. This will allow for clearer conversion and formatting to the FEBS Letters style by the typesetters. As articles undergo considerable conversion and transformation during production, we achieve the most efficient processing if articles are presented in as generic a form as possible.
After acceptance
Accepted Articles
FEBS Letters provides authors with Wiley’s Accepted Articles service, whereby peer reviewed, accepted articles, are published online within days of acceptance, without having been copyedited or typeset. The articles are available as a PDF and can be cited using their Digital Object Identifier (DOI) numbers. For more information on DOIs, please see http://www.doi.org/faq.html. Please note, as Accepted Articles are not considered to be final, changes may be made after the Accepted Article online publication date. Once copyedited and typeset, the article will be removed from the Accepted Articles area and will appear instead in Early View.
The implementation of the Accepted Articles service has been designed to ensure the earliest possible circulation of research papers immediately after acceptance, considerably reducing time to publication.
For tips on how to promote your article after publication see here.
Proofs
Page proofs will be sent electronically to the corresponding author, who will receive an e-mail alert containing a link to a secure web site for the proofs. A working e-mail address must therefore be provided for the corresponding author. In the absence of the corresponding author, please arrange for a colleague to access the e-mail to retrieve the proofs. Please note that you (ie ALL authors) have final responsibility for what is stated in the proofs of your manuscript.
Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editorial Office. Note that Wiley may proceed with the publication of your article if no response is received within 48 hours.
Article Promotion Support
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.
Early View
FEBS Letters uses Wiley-Blackwell's Early View service. Early View articles are complete and final full-text articles published online in advance of their publication in a printed issue. They are fully copyedited and typeset and therefore no changes can be made after an article is published in Early View. Authors should take this into account when planning their intellectual and patent activities related to a document. The nature of Early View articles means that they do not yet have volume, issue or page numbers. They can be referenced and tracked before being allocated to an issue by using the Digital Object Identifier (DOI). This will be the same DOI as assigned at Accepted Article stage. After print publication, the DOI remains valid and can continue to be used to cite and access the article. For more information on DOIs, please see http://www.doi.org/faq.html.
Embargo period
FEBS Letters follows a subscription-based model with a delayed and hybrid open access policy. All articles are made available to non-subscribers for free after 12 months, with Review articles being available for free immediately.
Permissions
Authors or a third party wishing to reproduce figures, tables or brief quotations from the text of articles published in FEBS Letters for non-commercial purposes may do so, providing the original publication is acknowledged accordingly and the authors' approval is obtained. No special permission is needed from FEBS or Wiley. If authors or a third party wish to use a major part of an article or an entire article elsewhere, whether in English or any translation, permission must be asked from Wiley, who will if necessary contact FEBS, the copyright holder.
Offprints
Free access to the final PDF of the article will be available via Author Services only. Reprints can be purchased at current printing prices.
Online production tracking
Wiley's Author Services platform allows authors to track the production status of their article, opt in to open access publication, and gain free access to their final published article and share the free access with up to 10 colleagues.
You can also check Wiley's Author FAQs.
Copyright and open access options
Copyright
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to access the copyright transfer agreement (CTA). The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs at the following link: CTA Terms and Conditions
Open access options
FEBS Letters follows a subscription-based model with a delayed and hybrid open access policy. All articles are made available to non-subscribers for free after 12 months, with Review articles being available for free immediately. Additionally, FEBS Letters offers authors the option to sponsor open access to their articles on Wiley Online Library. Authors can only select this option after receiving notification that their article has been accepted for publication. This prevents a potential conflict of interest where FEBS Letters would have a financial incentive to accept an article.
The author charge for open access is 3,300 USD.
If the hybrid Open Access option is selected, the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Licensing FAQs hosted on Wiley Author Services and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the Open Access option and your research is funded by certain funders [e.g. The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF)] you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
Publication and page charges
There are no page charges, colour figure charges, or any other publication charges for publishing in FEBS Letters.
Funding body agreements and policies
FEBS Letters complies with all funder open access requirements - including those of the Wellcome Trust, the Research Councils UK and the NIH. Please see here for our funding policy finder.
Frequently asked questions
How much does it cost to publish in FEBS Letters?
There are no page charges, colour figure charges, or any other publication charges for publishing in FEBS Letters.
Can I submit my manuscript in any format?
There are no strict formatting requirements for initial submissions. However, all manuscripts must contain the essential elements needed to convey your manuscript: Title, Author names and affiliations, Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Figures and Tables with Captions. If your article includes any Videos and/or other Supplementary material, this should be included in your initial submission for review purposes.
Does the journal accept submissions that have been posted on a preprint server?
FEBS Letters supports rapid and open scientific communication. Authors are free to upload their work to their personal website, their company’s/institution’s repository or archive, or a not-for-profit subject-based preprint server or repository ahead of or concurrently with submission to the Journal. Posting a manuscript to a recognised preprint server does not constitute prior publication.
Does FEBS Letters offer fast-track publication?
FEBS Letters offers expedited handling of manuscripts that have been rejected with reviews from highly ranked journals. The submission should enclose reviews, comments from the editor, and the final decision letter. You will receive a decision from the handling Editor or the Editorial Office within a few days of submitting your manuscript.
Does the journal have open-access options?
FEBS Letters offers authors the option to sponsor non-subscriber access to their articles on Wiley Online Library via the Open Access in a hybrid journal option. Authors can only select this option after receiving notification that their article has been accepted for publication. This prevents a potential conflict of interest where FEBS Letters would have a financial incentive to accept an article.
If the Open Access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
Author Enquiries
Contact us
For questions on the submission or reviewing process, please contact the Editorial Office at febs.letters@bzh.uni-heidelberg.de. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
